In conclusion, puerarin protected the IRI of the fatty liver by regulating PI3K/AKT signaling pathway, and inhibition of PI3K-AKT with LY294002 attenuated the protective effect of puerarin. The gene discussed is AKT1; the disease is Hepatic steatosis.